Dr Lal Pathlabs Share Price Target 2022, 2023, 2024, 2025, 2030:- The company was founded as ‘Dr. Lal Pathlabs Private Limited’, a private limited company under the Companies Act with a certificate of incorporation issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana in Delhi.
So in this article we try to give Dr. Lal Pathlabs Share a new path through technical and fundamental analysis.
Dr Lal Pathlabs Share Price Target 2022
The company focuses on providing quality diagnostic and related health tests and services to patients. The company’s focus on the patient as the customer is a critical differentiator in the diagnostic and healthcare industry and, along with its brand recognition for quality diagnostic services, leads individuals and healthcare providers to choose it as their diagnostic healthcare provider. This is because in India patients usually choose their diagnostic healthcare provider and patients and healthcare providers look for quality healthcare providers due to the extent of quality and reliability of diagnostic healthcare services in India.
The target price of the two target shares in Dr. Lal Pathlabs was reached by 2022. The target price of the first share of Dr. Lal Pathlabs was valued at Rs 2700. And the second target prize of Dr. Lal Pathlabs can be found around Rs 2850.
| Year | Dr Lal Pathlabs Share Price Target 2022 |
|---|---|
| First Target 2022 | Rs 2700 |
| Second Target 2022 | Rs 2850 |
Also read:- Bharat Rasayan Share Price Target 2022, 2023, 2024, 2025, 2030
Dr Lal Pathlabs share price target 2023
With over 3,368 diagnostic and related health tests and services offered, the company is able to perform virtually all diagnostic health tests and services currently prescribed by doctors in India. Its diagnostic and allied health tests and services include routine clinical laboratory tests such as blood chemistries and blood cell counts, and specialized testing services such as histopathological analysis, genetic marker-based tests, viral and bacterial cultures, and infectious disease tests and services preventive testing, such as screening for hypertension, heart disease and diabetes. It performs these tests and services in its clinical laboratories using sophisticated and computerized equipment.
Target number of shares Dr. Lal Pathlabs could enter around 2023. The target price of Dr. Lal Pathlabs by 2023 is estimated at Rs 3200. And the second target prize Dr. Lal Pathlabs was able to cover around Rs 3400.
| Year | Dr Lal Pathlabs Share Price Target 2023 |
|---|---|
| First Target 2023 | Rs 3200 |
| Second Target 2023 | Rs 3400 |
Also read:- Newgen Software Share Price Target 2022, 2023, 2024, 2025, 2030
Dr Lal Pathlabs Share Price Target 2024
The company has built a national “hub and spoke” network that includes its National Reference Laboratory in New Delhi. The company’s “hub and spoke” model, where samples are collected at multiple locations within the region and delivered to a pre-designated clinical laboratory for centralized diagnostic testing, provides greater economies of scale and offers a scalable platform for the continued growth of its business.
Its network is present across India including major cities like New Delhi, Mumbai, Bengaluru, Chennai, Hyderabad and Kolkata. The company’s centralized information technology platform fully integrates its extensive network through a common logistics and payment system and monitors its operations and internal performance metrics, allowing it to increase the efficiency of its business.
At the moment we are trying to predict the price of two stocks that Dr. Lal Pathlabs will be acquired in 2024. Initial target price Dr. Lal PathLabs is estimated at Rs 3700. And the second target prize Dr. Lal Pathlabs is estimated at Rs 4000.
| Year | Dr Lal Pathlabs Share Price Target 2024 |
|---|---|
| First Target 2024 | Rs 3700 |
| Second Target 2024 | Rs 4000 |
Also read:- GNFC Share Price Target 2022, 2023, 2024, 2025, 2030
Dr Lal Pathlabs Share Price Target 2025
The company is a provider of diagnostic and allied health tests and services in India. Through its integrated nationwide network, the company offers patients and healthcare providers a wide range of diagnostic and related health tests and services for use in basic testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers, and corporate customers.
Here we try to analyze the price of two target stocks Dr. Lal Pathlabs which can be acquired by 2025. Actual target price of Dr. Lal Pathlabs was valued at Rs 4500. And the second goal of the share price of Dr. Lal Pathlabs by 2025 is around Rs 4800.
| Year | Dr Lal Pathlabs Share Price Target 2025 |
|---|---|
| First Target 2025 | Rs 4500 |
| Second Target 2025 | Rs 4800 |
Also read:- Biogen Pharmachem Share Price Target 2022, 2023, 2024, 2025, 2030
Dr Lal Pathlabs Share Price Target 2030
Dr Lal Pathlabs has launched a pilot project to use drones to transport blood samples. The use of drones would extend Dr. Lal Pathlabs services to inaccessible places. Pilot projects are being launched in many remote, semi-urban and rural locations to test different use cases that eliminate issues such as traffic congestion, poor road conditions and inaccessibility. The company is launching pilot projects in different parts of the country.
Target price Dr. Lal Pathlabs for these two stocks could be set by the end of 2030. The initial target price of Dr. Lal Pathlabs will be able to make a profit of Rs 8500 in FY 2030. Dr Lal Pathlabs second target price at the end of this decade is close to Rs 9000.
| Year | Dr Lal Pathlabs Share Price Target 2030 |
|---|---|
| First Target 2030 | Rs 8500 |
| Second Target 2030 | Rs 9000 |
Also read:- JTL Infra Share Price Target 2022, 2023, 2024, 2025, 2030
Future Prospectus of Dr Lal Pathlabs share
- Dr Lal Pathlabs has launched a pilot project to use drones to transport blood samples. The use of drones would extend Dr. Lal Pathlabs services to inaccessible places.
- Pilot projects are being launched in many remote, semi-urban and rural locations to test different use cases that eliminate issues such as traffic congestion, poor road conditions and inaccessibility. The company is launching pilot projects in different parts of the country.
Dr Lal Pathlabs Share Price Target 2022, 2023, 2024, 2025, 2030 Table
| Year | Dr Lal Pathlabs Share Price Target |
|---|---|
| First Target 2022 | Rs 2700 |
| Second Target 2022 | Rs 2850 |
| First Target 2023 | Rs 3200 |
| Second Target 2023 | Rs 3400 |
| First Target 2024 | Rs 3700 |
| Second Target 2024 | Rs 4000 |
| First Target 2025 | Rs 4500 |
| Second Target 2025 | Rs 4800 |
| First Target 2030 | Rs 8500 |
| Second Target 2030 | Rs 9000 |
Risk of Dr Lal Pathlabs share
- Dr. Lal Pathlabs needs more funding to realize its full potential across the industry or Dr. Lal Pathlabs able to bring benefits or returns to its investors in the coming years.
- Dr. Lal pathlabs has a huge debt to the company which needs to be reduced in the coming years or else they will borrow all the sales or annual income to pay off their debts.
Expert Views on Dr Lal Pathlabs share
After analyzing all the factors, we can say that it is the best time to invest in Dr. Lal Pathlabs that will offer the best value for years to come.
Dr Lal Pathlabs share F.A.Q.
– Where is the headquarters of Dr Lal Pathlabs located?
Dr Lal Pathlabs Located in Gurgaon, Delhi NCR.
– Who is the MD of Dr Lal Pathlabs?
The MD of Dr Lal Pathlabs is Om Manchanda.
– In which business Dr Lal Pathlabs is involved?
Dr. Lal Pathlabs is a provider of diagnostic and related healthcare tests and services in India.
I hope that after reading the article Dr Lal Pathlabs Share Price Target 2022, 2023, 2024, 2025, 2030 you must have got a good idea what kind of performance can be seen in the growth of the Company. If you still have any question related to this article in your mind, then do not forget to tell in the comment at all. Stay tuned to Market in India for important information about this type of stock in the stock market.
Also read:-
